Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes

Mariette, C.; Gronnier, Caroline; Duhamel, Alain; Mabrut, Jean‐Yves; Bail, Jean‐Pierre; Carrère, Nicolas; Lefèvre, Jérémie H.; Meunier, Bernard; Collet, Denis; Piessen, Guillaume; Dhahri, Abdennahceur; Lignier, Delphine; Cossé, Cyril; Régimbeau, Jean‐Marc; Luc, G.; Cabau, Magalie; Jougon, Jacques; Lozac’h, P.; Thereaux, Jéremie; Badic, Bogdan; Cappeliez, Serge; Nakadi, Issam El; Lebreton, Gil; Alvès, Arnaud; Flamein, Renaud; Pezet, Denis; Pipitone, Federica; Stan-Iuga, Bogdan; Contival, Nicolas; Pappalardo, Eric; Msika, Simon; Mantziari, Styliani; Hec, Flora; Vanderbeken, Marguerite; Tessier, Williams; Briez, Nicolas; Fredon, Fabien; Gainant, A; Mathonnet, Muriel; Mezoughi, Salim; Ducerf, C.; Baulieux, J.; Bigourdan, Jean-Marc; Pasquer, Arnaud; Baraket, Oussama; Poncet, Gilles; Adam, M.; Vaudoyer, Delphine; Enfer, Peggy Jourdan; Villeneuve, Laurent; Gléhen, Olivier; Coste, Thibault; Fabre, Jean‐Michel; Marchal, Frédéric; Frisoni, Romain; Ayav, Ahmet; Brunaud, Laurent; Bresler, L.; Cohen, Charlotte; Aze, Olivier; Vénissac, Nicolas; Pop, Dániel; Mouroux, Jérôme; Donici, Ion; Prudhomme, Michel; Felli, Emanuele; Lisunfui, Stéphanie; Seman, Marie; Petit, Gaëlle; Karoui, Mehdi; Trésallet, Christophe; Ménégaux, Fabrice; Vaillant, Jean‐Christophe; Hannoun, L.; Malgras, Brice; Lantuas, Denis; Pautrat, Karine; Pocard, Marc; Valleur, Patrice; Chafaı̈, Najim; Balladur, Pierre; Lefrançois, Magalie; Parc, Yann; Paye, François; Tiret, Emmanuel; Nedelcu, Marius; Laface, Letizia; Perniceni, Thierry; Gayet, Brice; Turner, Kathleen; Filipello, Alexandre; Porcheron, J.; Tiffet, Olivier; Kamlet, Noémie; Chemaly, Rodrigue; Klipfel, Amandine; Pessaux, Patrick; Brigand, Cécile; Rohr, S.; Rieu, M. Chalret du; Re, Chiara; Dumont, Frédéric; Goèré, Diane; Élias, Dominique; Bertrand, Claude

doi:10.1016/j.jamcollsurg.2014.11.028

Cited by 68 publications

(54 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…38 Nutritional assessment is recommended as malnutrition is common, and if enteral feeding is required, jejunostomy placement is preferable to stenting for resectable cancer. 38,56 …”

Section: Oncological Treatmentmentioning

confidence: 99%

Oesophageal cancer

et al. 2017

View full text Add to dashboard Cite

SummaryOesophageal cancer is a clinically challenging disease requiring a multidisciplinary approach.The extensive treatment may be associated with serious limitations in health-related quality of life and yet still a poor prognosis. Recent decades have witnessed a gradual improvement in prognosis in many countries. Endoscopic procedures have increasingly been used in the treatment of premalignant and early oesophageal tumours. Neoadjuvant therapy with chemotherapy or chemoradiotherapy has supplemented surgery as standard treatment of locally advanced oesophageal cancer. Surgery has become more standardised and centralised. There are several therapeutic alternatives for palliative treatment. This review aims to provide insights into the current clinical management, on-going controversies and future needs in oesophageal cancer.3

show abstract

“…38 Nutritional assessment is recommended as malnutrition is common, and if enteral feeding is required, jejunostomy placement is preferable to stenting for resectable cancer. 38,56 …”

Section: Oncological Treatmentmentioning

confidence: 99%

Oesophageal cancer

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Mariette et al reported that SEMS, as a bridge to surgery, has a negative impact on outcome in patients with esophageal carcinoma, resulting in less R0 resections, earlier recurrences, a decreased 3-year overall survival, and an increased 3-year locoregional recurrence rate [45].…”

Section: Resultsmentioning

confidence: 99%

Gastrointestinal stenting: Current status and imaging features

Malgras

Dico

Pautrat

et al. 2015

Diagnostic and Interventional Imaging

View full text Add to dashboard Cite

The use of stents in the gastrointestinal tract has been subjected to major changes. Initially, the use of stents was restricted to malignant strictures in patients with metastatic disease. But thanks to reduction of the morbidity and mortality rates, they are now used with curative intention and in patients with benign diseases after careful selection. However, for patients presenting with colon obstruction due to an advanced colon carcinoma, the mortality and morbidity are still high. The purpose of this review is to provide an overview of indications, techniques and further developments of the stents in the gastrointestinal tract and to highlight the predominant role of multidetector row computed tomography (MDCT) in the detection of potential complications.

show abstract

“…Because most of patients suffer from dysphagia due to balk of tumor lesion and unfortunately are un-resectable at the diagnosis time [1][2]. Endoscopic placement of stents has been shown to rapid dysphagia relief [1,3,[13][14]. Maintenance of oral intake, nutritional support, manage mouth secretions, and reduce aspiration risk are essential for these patients [12][13].…”

Section: Introductionmentioning

confidence: 99%

“…Endoscopic placement of stents has been shown to rapid dysphagia relief [1,3,[13][14]. Maintenance of oral intake, nutritional support, manage mouth secretions, and reduce aspiration risk are essential for these patients [12][13]. Guidelines illustrated some indications for stent use in esophageal neoplasm including inoperable neoplastic obstruction, presence of neoplastic fistula or leakage or perforation, tumor recurrence and contraindication for chemo-radiotherapy [10,[15][16].…”

Section: Introductionmentioning

confidence: 99%

Palliation of Neoplastic Esophageal Strictures with Metallic Stents

Nozari¹

2017

JCTR

View full text Add to dashboard Cite

Abstract:Most patients with advanced esophageal neoplasm have dysphagia and suffer from cachexia and malnourishment.Supportive treatments focus on symptom palliation and improving quality of life at this time. Guidelines illustrated some indications for stent use in esophageal neoplasm such as inoperable neoplastic obstruction, presence of neoplastic fistula or perforation, tumor recurrence and contraindication for chemo-radiotherapy. Palliative stents help relieve dysphagia, manage mouth secretions, reduce aspiration risk, and maintain oral intake. Stent placement sometimes requires both endoscopic and fluoroscopic guidance. A stricture dilation is not necessary before stent placement. Success rate of SEMS placement was reported 80-100%. Complications of stents are bleeding, perforation, migration, and tumor ingrowth. Coated SEMS are the treatment of choice in the presence of neoplastic trachea-esophageal fistula. Partially covered stents are used for neoplastic stricture but their removal is sometimes difficult. The stent can be left in esophagus indefinitely for palliation in cases with progressive disease. In this article, we reviewed the recent literatures for efficacy of palliative metal stents placement in patients with esophageal neoplasm.

show abstract

Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes

Cited by 68 publications

References 29 publications

Oesophageal cancer

Oesophageal cancer

Gastrointestinal stenting: Current status and imaging features

Palliation of Neoplastic Esophageal Strictures with Metallic Stents

Contact Info

Product

Resources

About